Phylo unveils Biomni Lab and seed round co-led by A16Z and Menlo Ventures Read more →

Use CasesEnterpriseResearchBlog

Company

Pricing
Biomni Labarrow
Biomni Lab for Enterprises

TheNewWayLifeSciencesTeamsWork

BiomniLabisalreadybelovedbytensofthousandsofscientistsacrossleadingpharma,biotech,andacademicorganizations.

Trustedbyteamsatglobalbiopharma

0K+

life science organizations already use Biomni Lab

0X+

faster hypothesis-to-analysis cycles reported by lab teams

0K+

scientists use Biomni to run their workflows

Stanford University
Broad Institute
Ono Pharmaceutical Co., Ltd.
Alumis
UC San Diego
UCSF
and more

HowteamsuseBiomniLab

Fromearlybiologytotheclinic,oneplatformeveryteamcanuse.

Early discoveryTarget validationHit to leadLead optimizationClinical
Early discovery

Discovery Biology

Build consensus disease signatures across public omics datasets

Cluster and annotate cell types in single-cell atlases

Map spatial transcriptomics onto tissue architecture

Target validation

Human Genetics

Map GWAS loci to causal genes with fine-mapping and Mendelian randomization

Review tractability, druggability, and tissue-specific safety

Gate candidates on genetic constraint and direction of effect

Hit to lead

Medicinal Chemistry

Run large-scale virtual screens and triage the hits

Design molecules generatively with synthesizable routes

Predict ADMET properties and dock against the structure

Hit to lead

Protein Sciences and Biologics

Predict protein structure and binding mode

Design de novo binder and antibody candidates in silico

Assess developability, immunogenicity, and humanization

Lead optimization

Preclinical Safety and DMPK

Model population PK and exposure-response to inform dose selection

Predict off-target, hERG, and secondary-pharmacology liabilities

Detect adverse-event signals in public pharmacovigilance data

Clinical

Clinical Development

Analyze real-world outcomes on your EHR and claims data

Run survival analysis and stratify patient risk

Synthesize evidence systematically with meta-analysis

Accelerating everyday discovery

“With patients waiting for new medicines, there is an urgent need to help scientists move faster without compromising scientific rigor. Biomni Lab stood out because our researchers quickly adopted it and saw its potential to accelerate everyday discovery. We look forward to working with Phylo to explore how agentic AI can help bring new medicines to patients faster.”

Read the announcement here

Seishi Katsumata, Ph.D.

Corporate Officer, Executive VP, Discovery & Research

Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd.
Omics and imaging analysis

“Biomni Lab is user-friendly for all scientists to automate bioinformatics analyses, generate publication-quality figures, and even compare results with external datasets. At Ginkgo Datapoints, we hope to incorporate Biomni as an everyday tool in our workflows.”

Read the case study

Ayla Ergun

Senior Director of Data Science

Ginkgo Bioworks

Ginkgo Bioworks
Hypothesis testing & refinement

“While researching a specific protein’s role in a disease, Biomni didn’t just return accurate references to support my hypothesis; it actually found a paper with data buried in one of its figures that contradicted my hypothesis. It reinterpreted those findings and helped me refine my hypothesis in a way I hadn’t previously considered. That level of critical thinking and analysis is something I haven’t seen in other AI platforms; it truly felt like collaborating with a subject matter expert… [Biomni has] become an essential part of my workflow.”

Ashkan Javaherian, PhD

Neuroscientist

Biotech Executive

CRISPR screen analysis

“Biomni Lab turned a CRISPR screen workflow that took nearly 20 hours into one I can complete in under 30 minutes—a roughly 40× speedup. More importantly, it made iteration easy enough to explore parameters freely, leading to better-supported hit calls and more confident conclusions. The bottleneck moved from mechanical execution to scientific decision-making.”

Lai Wei

Project Scientist

UCSD

UC San Diego
Exploratory data analysis

“Biomni Lab has fundamentally changed how I approach data analysis. Instead of spending days or weeks coordinating iterative requests, I can explore datasets, test hypotheses, and generate publication-quality analyses myself. It has already contributed to several grants in preparation, and its clear documentation makes the work easier to understand, reproduce, and build upon.”

Ezequiel Dantas, MD, PhD

Assistant Professor

NYU Langone

NYU Langone Health
Compound screening & docking

“We used Biomni Lab to screen tens of thousands of compounds, generate docking profiles against crystal structures, and identify a shortlist of leads for empirical testing. This would have been extremely difficult without a medicinal chemistry or structural biology collaboration. Biomni has become a staple in our lab, helping us take on work that was previously out of reach.”

Rahul Bhansali, MD

Clinical Instructor / Postdoctoral Fellow

University of Pennsylvania / Children’s Hospital of Philadelphia

University of Pennsylvania
Multi-omic atlas building

“My lab used Biomni Lab to build a preliminary atlas of publicly available transcription factor perturbations and epigenomic measurements. What would have taken one to two weeks became a single day of guiding the agent. That early atlas gave us the proof of feasibility we needed to take the project forward.”

Sahin Naqvi, PhD

Assistant Professor / PI

Boston Children’s Hospital & Harvard Medical School

Harvard Medical School

DesignedforEnterpriseTrust

Scientifically valid

Clarifies what you're asking before starting, checks its reasoning against a biology knowledge graph, and reviews its own work with traceable references before handing it to you.Read more about our benchmarking

Reproducible

100+ pre-built agentic workflows across the biopharma value chain, with deterministic pipelines for fully reproducible results.

Model-agnostic

Use the best-performing models across a wide range of scientific research tasks while keeping costs in check.

Private by design

Your data stays within your own secure enterprise boundaries, and can be deployed into your own VPC—never used to train models.

footer banner

Ready to make discoveries faster?